Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).

In a new study, researchers looked to identify unique biomarkers and shared microbial mechanisms among different autoimmune ...

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...

Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).

In a new study, researchers investigated the prevalence of cardiovascular disease events (CVE) in people with systemic lupus ...

In a recent study, researchers explored the association between HCQ and the overall risk of CV events in people with SLE.

The PALIZADE clinical study is evaluating zetomipzomib for the treatment of lupus nephritis, its side effects, and how it affects proteins in the urine. The PALIZADE clinical trial is made up of 3 ...

Autoimmune diseases, including systemic lupus erythematosus (SLE), are more common in women than men, and scientists are ...